Therefore, besides showing that CT26-tumor bearing mouse is a robust model to study cachexia, these results indicate that, at late stages, this model does not present significant changes on the proteolytic status represented by the ubiquitin-proteasome system. This evidence concerns the gene DDX53 and neoplasm.